Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Evaluating the Safety and Efficacy of the Dexamethasone, Azacytidine, Pegaspargase, Tislelizumab With NK/T Cell Lymphoma

NCT04899414 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT04899414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04899414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Evaluating the Safety and Efficacy of the Dexamethasone, Azacytidine, Pegaspargase, Tislelizumab With NK/T Cell Lymphoma
Lead sponsor
Peking University
Phase
Phase 2
Overall status
Unknown status
Start date
May 18, 2021
Completion date
October 18, 2023
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

nk/t cell lymphoma